Profile data is unavailable for this security.
About the company
Beijing Foyou Pharma Co Ltd, formerly Beijing Winsunny Pharmaceutical Co Ltd, is a China-based company mainly engaged in the research, development, production and sales of pharmaceutical preparations and medical devices. The Company's pharmaceutical preparations mainly cover the fields of cardiovascular system, chronic kidney disease, skin disease, digestive system, diabetes, mental nervous system, gynecology and others. The Company's pharmaceutical preparation products mainly include tablets, ointments, creams, gels, soft capsules, solutions, syrups, tinctures, sprays, hard capsules and others. The Company's medical device business focuses on humidification and oxygen inhalation devices, and its main products include disposable oxygen inhalation tubes and others. The Company mainly operates its businesses in the domestic and overseas markets.
- Revenue in CNY (TTM)3.32bn
- Net income in CNY507.64m
- Incorporated1999
- Employees3.44k
- LocationBeijing Foyou Pharma Co LtdBEIJING 101113ChinaCHN
- Phone+86 1 059603941
- Fax+86 1 059603942
- Websitehttp://www.foyou.com.cn/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JiangSu WuZhong Pharmactcl Devlpm Co Ltd | 2.33bn | -95.04m | 6.43bn | 1.05k | -- | 3.63 | -- | 2.76 | -0.1335 | -0.1335 | 3.22 | 2.48 | 0.553 | 16.07 | 2.29 | 2,220,525.00 | -2.31 | -2.92 | -4.78 | -5.30 | 22.41 | 28.14 | -4.18 | -5.77 | 1.22 | -0.3232 | 0.5063 | -- | 10.55 | 5.65 | 5.58 | -- | -19.08 | -- |
| Cisen Pharmaceutical Co Ltd | 4.48bn | 528.35m | 6.46bn | 3.40k | 12.26 | 1.10 | -- | 1.44 | 1.16 | 1.16 | 9.86 | 13.02 | 0.6082 | 2.81 | 5.65 | 1,315,959.00 | 7.21 | 6.94 | 9.02 | 8.56 | 57.33 | 56.27 | 11.85 | 10.77 | 3.12 | -- | 0.0373 | 33.42 | 9.75 | 3.22 | 48.92 | 0.697 | -15.19 | 10.72 |
| Beijing Foyou Pharma Co Ltd | 3.32bn | 507.64m | 6.58bn | 3.44k | 12.91 | 1.87 | -- | 1.98 | 1.06 | 1.06 | 6.95 | 7.35 | 0.7482 | 3.46 | 9.58 | 967,165.90 | 11.50 | -- | 14.81 | -- | 65.14 | -- | 15.37 | -- | 2.99 | -- | 0.0316 | -- | 3.07 | -- | 11.36 | -- | -- | -- |
| Harbin Pharmaceutical Group Co., Ltd. | 15.67bn | 449.71m | 6.63bn | 9.85k | 14.39 | 1.35 | -- | 0.4232 | 0.1827 | 0.1827 | 6.34 | 1.95 | 1.13 | 6.35 | 3.46 | 1,590,093.00 | 3.79 | 0.7414 | 10.20 | 1.89 | 26.30 | 23.87 | 3.35 | 0.7294 | 1.06 | 40.41 | 0.393 | 0.00 | 11.93 | 7.41 | -14.88 | 2.69 | -5.38 | -- |
| Shouyao Holdings Co Ltd | 5.23m | -191.79m | 6.67bn | 185.00 | -- | 6.89 | -- | 1,274.99 | -1.29 | -1.29 | 0.0352 | 6.51 | 0.0045 | 0.2644 | 5.25 | 28,265.68 | -16.55 | -37.24 | -18.01 | -42.63 | 96.50 | 96.03 | -3,667.74 | -2,251.77 | 8.49 | -- | 0.0018 | -- | 186.18 | -23.51 | -6.76 | -- | 34.59 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 8.10m | 3.95% |
| E Fund Management Co., Ltd.as of 05 Feb 2024 | 5.87m | 2.86% |
| Essence Fund Co., Ltd.as of 31 Dec 2023 | 1.93m | 0.94% |
| CIB Fund Management Co., Ltd.as of 31 Dec 2023 | 953.70k | 0.46% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2023 | 591.40k | 0.29% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 560.60k | 0.27% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 469.95k | 0.23% |
| Truvalue Asset Management Co. Ltd.as of 31 Dec 2023 | 451.50k | 0.22% |
| Changsheng Fund Management Co., Ltd.as of 31 Dec 2023 | 247.70k | 0.12% |
| BlackRock Advisors LLCas of 31 May 2024 | 157.70k | 0.08% |
